Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, will present 11 abstracts ...
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a noninvasive ...
Between now and March 7, fans can get a free ticket to Round 2 of the Cologuard Classic via a $5 donation to the Community Food Bank of Southern Arizona.
Investor's Business Daily on MSN5d
Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'Exact Sciences stock crumbled Thursday on its growing rivalry with Guardant Health and Natera in colon cancer screening.
Instead of a Cologuard version of the Sinatra standard, spots reference "Game of Thrones" and "Real Housewives." ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on EXAS stock, giving a Buy rating yesterday.Stay Ahead of the ...
Exact Sciences' 2024 sales grew 10% to $2.76 billion, exceeding estimates. New cancer tests, including Cologuard Plus, are ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.CDDzvsGh.js ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback